tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Hartaj Singh, 166 are a BUY (95.95%), 1 are a SELL (0.58%), 6 are a HOLD (3.47%).
Analyst Hartaj Singh, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 40.66% that have a potential upside of 27.33% achieved within 202 days.
Hartaj Singh’s has documented 331 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMEA, Biomea Fusion at 06-Aug-2025.
Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for MRNA (MODERNA) at 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%) receiving and performance score of 77.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2015
$205
$22.5 (12.33%)
$150
4 years 9 months 10 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 23-Mar-2021
$173
$-9.5 (-5.21%)
$156
4 years 9 months 12 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 11 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold Since 14-Dec-2020
$190
$7.5 (4.11%)
$194
5 years 11 days ago
(04-Feb-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Hold Since 04-Feb-2021
$166
$-16.5 (-9.04%)
$175
5 years 11 days ago
(04-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
What Year was the first public recommendation made by Hartaj Singh?
